T1	Participants 418 462	Sixty obese women were included in the study
T2	Participants 464 551	Subjects were divided into 2 equal groups-the placebo and sibutramine treatment groups.
T3	Participants 553 617	he sibutramine group was given sibutramine 10 mg daily for 12 wk
T4	Participants 758 842	Subjects were examined at weeks 4, 8, and 12 of treatment to identify adverse effect
